Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Hetero
1X10 tablets
Anastrozole
Keep in cold place
Delivering To:
Overview
Anatero tablet, a drug used in cancer treatment, belongs to a class of medications known as aromatase inhibitors. This group of drugs is used to combat certain types of breast cancer in women. Aromatase inhibitors work by targeting an enzyme called aromatase, which is responsible for producing estrogen in the body. By reducing the amount of estrogen in the body, aromatase inhibitors reduce the growth of specific breast cancer cells by lowering the amount of estrogen they require to survive and grow.
Breast Cancer
Breast cancer
The side effects of the Anatero tablet can include:
Hot flashes
Headaches
Joint pain
Decrease in sexual desire or libido.
High blood pressure
Increased cholesterol levels
Increased risk of osteoporosis in some people.
It is important to discuss the risks and benefits of Anastrozole with your doctor before starting the treatment.
As a prescription drug, Anatero tablet is typically taken in oral tablet form and just once a day. It has a very long half-life and can take up to eight weeks to reach maximum effectiveness in the body. Common side effects of the tablet include joint pain, hot flashes, headaches, anxiety, depression, nausea, and weight gain. As a medication, anastrozole is highly effective at treating certain types of breast cancer. Studies have found that it can reduce the risk of recurrence of hormone receptor-positive early-stage breast cancer by up to 65 percent. It is also incredibly safe and well-tolerated when taken alone or combined with other cancer drugs.
Anatero tablet dose has numerous potential benefits for both women and men. By blocking the production of hormones like estrogen and testosterone, an Anastrozole dose can reduce the risk of cancer, alleviate symptoms associated with conditions like PCOS and endometriosis, and help relieve the effects of menopause. Anastrozole effects can also reduce the risk of osteoporosis and heart disease. While Anastrozole's effects may have potential risks, its potential to help people in many different ways makes it a valuable medication for an array of conditions.
Alcohol
unsafe
It is advisable not to consume alcohol while taking the Anatero tablet. It is suggested that you consult your doctor.
Pregnancy
consult your doctor
Do not take the Anatero tablet without consulting a doctor in case of pregnancy. Anatero tablet is considered not safe to use in case of pregnancy as it may harm the developing baby, according to research evidence.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding. Anatero tablet may cause toxicity to the developing baby as it may be transferred through the milk of the mother, so it's not considered safe to use Anatero tablet during breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, as one of the side effects of the medicine. Anatero tablet can make you feel sleepy, affect your vision, and affect your alertness. It is advised not to drive if these symptoms exist while taking the Anatero tablet
Kidney
caution
Do not take the Anatero tablet without a doctor's consultation in case of kidney problems. Patients with severe kidney disease should use Anatero tablet with caution, and the patient may require an adjustment in dose as recommended by the doctor. A Regular kidney test should be done to monitor the side effects of Anatero tablet on the kidneys.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine. Patients with severe Liver disease should use Anatero tablet with caution, and the patient may require an adjustment in dose as recommended by the doctor. A Regular liver test should be done to monitor the side effects of Anatero tablet on the liver.
It is advisable not to miss any dose. In case you miss a dose of Anatero 1mg tablet consult your doctor soon.
Missing the dose will impact the overall health of the patients. So, it is always advisable to follow the prescription of the doctor strictly.
The drug works by inhibiting the activity of the aromatase enzyme, which is found in cancer cells, and promotes the conversion of androgen hormones into estrogen. This may stop the production of estrogen and cause the growth of cancer cells to slow down.
The medicine has various side effects including an increased risk of bone fractures, cataracts, decreased breast milk, diabetes, diarrhea, dizziness, dry skin, fluid retention, hair loss, headache, hot flashes, increased blood pressure
The recommended dose is 1 mg/day by mouth. It may be taken with or without food. If you are taking it with food, take the tablet with a meal (preferably breakfast) containing fats.
The medicine works by blocking the production of estrogen and is used in patients who still have active estrogen receptors that can produce cancer growth.
The drug is primarily used for the treatment of breast cancer. It is sometimes used as a supplementary drug to treat other types of cancers, but these are under experimental stages.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Kobayashi K, Okuno N, Arai G, Nakatsu H, Maniwa A, Kamiya N, Satoh T, Kikukawa H, Nasu Y, Uemura H, Nakashima T, Mikami K, Iinuma M, Tanabe K, Furukawa J, Kobayashi H.(2024). Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study. Jpn J Clin Oncol. 51(4):544-551.
Madan R, Dahut WL. (2022) Abiraterone's efficacy confirmed; time to aim higher. Lancet Oncol. 16(2):119-21.
Ryan CJ, Smith MR, Fizazi K, Saad F, Mulders PF, Sternberg CN, Miller K, Logothetis CJ, Shore ND, Small EJ, Carles J, Flaig TW, Taplin ME, Higano CS, de Souza P, de Bono JS, Griffin TW, De Porre P, Yu MK, Park YC, Li J, Kheoh T, Naini V, Molina A, Rathkopf DE; COU-AA-302 Investigators. (2023). Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol. 16(2):152-60.
Saad F, Shore N, Van Poppel H, Rathkopf DE, Smith MR, de Bono JS, Logothetis CJ, de Souza P, Fizazi K, Mulders PF, Mainwaring P, Hainsworth JD, Beer TM, North S, Fradet Y, Griffin TA, De Porre P, Londhe A, Kheoh T, Small EJ, Scher HI, Molina A, Ryan CJ. (2023). Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. Eur Urol. 68(4):570-7.
Sidaway P. (2025). Urological cancer: abiraterone treatment improves overall survival in patients with mCRPC. Nat Rev Clin Oncol. Mar;12(3):128.
Sun Y, Zou Q, Sun Z, Li C, Du C, Chen Z, Shan Y, Huang Y, Jin J, Ye ZQ, Xie L, Lin G, Feng Y, De Porre P, Liu W, Ye D. (2025). Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study. Int J Urol. 404-11.
Zhou ZR, Liu SX, Zhang TS, Xia J, Li B.(2024). Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(3): 1313-1320.
Hetero
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.